Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Protein kinase C theta type | ||
Ligand | BDBM50517667 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1869432 (CHEMBL4370498) | ||
IC50 | 0.380000±n/a nM | ||
Citation | Kunikawa, S; Tanaka, A; Takasuna, Y; Tasaki, M; Chida, N Discovery of 2,4-diamino-5-cyanopyrimidine derivatives as protein kinase C theta inhibitors with mitigated time-dependent drug-drug interactions. Bioorg Med Chem27:790-799 (2019) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Protein kinase C theta type | |||
Name: | Protein kinase C theta type | ||
Synonyms: | KPCT_HUMAN | PRKCQ | PRKCT | Protein kinase C theta | Protein kinase C theta type (PRKCQ) | Protein kinase C, PKC; classical/novel | nPKC-theta | ||
Type: | Serine/threonine-protein kinase | ||
Mol. Mass.: | 81878.04 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Full-length human PKC theta (Panvera Catalog No. P2996). | ||
Residue: | 706 | ||
Sequence: |
| ||
BDBM50517667 | |||
n/a | |||
Name | BDBM50517667 | ||
Synonyms: | CHEMBL4540382 | ||
Type | Small organic molecule | ||
Emp. Form. | C30H37F3N6O2 | ||
Mol. Mass. | 570.649 | ||
SMILES | O[C@H]1CC[C@@H](CC1)NC1C2CC3CC1CC(CNc1nc(NCc4ccccc4OC(F)(F)F)ncc1C#N)(C3)C2 |r,wU:1.0,wD:4.7,TLB:12:13:40:10.11.39,12:11:8.13.14:40,THB:7:8:40:10.11.39,39:11:8:14.15.40,39:15:8:10.12.11,(52.94,-10.06,;54.12,-9.07,;53.85,-7.55,;55.02,-6.56,;56.48,-7.1,;56.75,-8.6,;55.57,-9.59,;57.65,-6.1,;59.1,-6.62,;60.85,-6.75,;61.3,-8.09,;62.45,-8.96,;60.82,-8.98,;60.37,-7.53,;61.6,-6.52,;63.22,-6.56,;64.55,-5.79,;65.89,-6.56,;65.89,-8.1,;64.56,-8.87,;64.56,-10.41,;63.23,-11.18,;63.23,-12.72,;61.89,-13.49,;60.56,-12.71,;59.23,-13.48,;59.23,-15.02,;60.57,-15.79,;61.9,-15.02,;63.23,-15.79,;63.24,-17.33,;63.24,-18.73,;62,-18.35,;64.49,-18.35,;65.9,-11.18,;67.23,-10.41,;67.23,-8.86,;68.56,-8.08,;69.89,-7.31,;63.64,-8.01,;62,-5.81,)| | ||
Structure |